580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. - Schotte, R.; Villaudy, J.; Kedde, M.; Pos, W.; Wagner, K.; Go, D.; Fatmawati, C.; Moiset, G.; Yasuda, E.; Cercel, M.; Frankin, E.; van Hal-van Veen, S.; et al. (Annals of Oncology, 2020)